OHSU acquires BSD-500 Hyperthermia System
April 14, 2016
The Company ended the quarter with a total of $5.7 million of cash and investments. On June 17, 2010, the Company secured a committed equity financing facility under which it may sell up to $15 million of common stock to Small Cap Biotech Value Ltd. over a 24 month period.
Recent Company HighlightsCelsion appointed Jeffrey W. Church as Chief Financial Officer.Patient enrollment for the Phase III Heat trial to date is over 67% complete. Efforts to stimulate patient enrollment continue with full enrollment expected by the end of this year remain a priority for the Company. ThermoDox?® Abstract presented at the American Society of Clinical Oncology 2010 Annual Meeting.Celsion announced ThermoDox?® Abstract accepted at the American Society for Radiation Oncology 2010 Annual Meeting.Celsion entered into a $15 Million Committed Equity Financing Facility with Small Cap Biotech Value, Ltd on terms favorable to traditional financing.
SOURCE Celsion Corporation